About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

RECRUITINGNANCT05853692

Prevention of Oral Mucositis in Head and Neck Cancer.

Oral Mucositis (OM) consists in the painful inflammation and ulceration of the mucous membranes lining the digestive tract, lasting between 7 and 98 days; and starts as an acute inflammation of oral m...

Lead sponsor: Catholic University of the Sacred Heart•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Contacts

Carlo Lajolo, Prof.

CONTACT

+393401004585 carlo.lajolo@unicatt.it

Sponsors

Lead Sponsor

Catholic University of the Sacred Heart

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Patients with diagnosis of the following HNC: oral cavity, pharynx, unknown primary, salivary glands, undergoing local radiotherapy for curative purpose
•Patients with diagnosis of HNC: oral cavity, pharynx, unknown primary, salivary glands, undergoing local radiotherapy as an adjuvant to surgical resection
•Patients able self-apply the product.

Exclusion Criteria

•Patients with documented contraindication to any of the components of "Gel X" (there included eccipients): water, saccharin sodium, PVP, Taurine, Zinc Gluconate, PEG-40, Hydrogenated castor oil, Pullulan, Flavors
•Patients with any neurological and psychiatric condition having an influence on the ability to self-apply the treatment
•Patients participating to other clinical studies

Related studies

RECRUITINGPhase 2

Traditional Chinese Medicine Oral Liquids and Mouthwashes for Radiation-induced Oral Mucositis in Head and Neck Cancer Patients

NCT07282483 · Radiation-induced Oral Mucositis

RECRUITINGPhase 2

Traditional Chinese Medicine Preparation Alleviates Radiotherapy-induced Oral Mucositis in Head and Neck Cancer Patients.

NCT07339774 · Radiotherapy-induced Oral Mucositis

RECRUITINGPhase 2

Spirulina-Derived Product Alleviates Oral Mucositis in Patients Undergoing Radiotherapy for Malignant Head and Neck Tumors

NCT07040969 · Radiation-induced Oral Mucositis

A Study on the Effectiveness of Olive Oil Mouthwash in Alleviating Chemoradiotherapy-induced Oral Mucositis in Patients With Head and Neck Cancer.

NCT07293013 · Oral Mucositis in Head and Neck Cancer, Chemo-radiotherapy

Correlation and Predictive Research of Metal Elements in Radiation-Induced Oral Mucositis

NCT06968520 · Head and Neck Tumors, Metal, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 19, 2026Terms

Trial snapshot

StatusRECRUITING

PhaseNA

Enrollment130

Start dateOct 2022

Last updatedMar 19, 2026

Condition

Locations shown

Catholic University of the Sacred Hearth

Roma, Italy

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 19, 2026Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions